The Boards of AbbVie ABBV and Shire SHPQ announced Friday, that they have reached agreement on the terms of a recommended merger of the two pharmaceutical companies. Under the terms of the merger, Shire Shareholders will be entitled to receive for each Shire Share £24.44 in cash and 0.8960 New AbbVie Shares. Both Boards have approved the transaction. The New AbbVie Shares are expected to be listed on the New York Stock Exchange.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in